LTFS
ODT

Ladenburg Thalmann Financial Services’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1K Buy
47
+33
+236% +$1.02K ﹤0.01% 5270
2019
Q3 		$0 Buy
+14
New +$468 ﹤0.01% 5549

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ODT Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Odonate Therapeutics, Inc. Common Stock (ODT) stake by 236% in Q4 2019, buying an estimated $1.02K and bringing the position to 47 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #5270.

Ladenburg Thalmann Financial Services first reported a position in ODT in Q3 2019 and has held it in 2 quarters since. 88 funds tracked by Wall St. Rank hold ODT as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 47 shares of Odonate Therapeutics, Inc. Common Stock worth $1K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 33 Odonate Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $1.02K.
  • Odonate Therapeutics, Inc. Common Stock made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5270 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Odonate Therapeutics, Inc. Common Stock in Q3 2019 and has held it in 2 quarters since.
  • 88 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.